D.E. Shaw & Co’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.3M | Buy |
1,297,383
+34,253
| +3% | +$457K | 0.01% | 778 |
|
|
2025
Q1 | $12.9M | Buy |
1,263,130
+1,251,031
| +10,340% | +$12.7M | 0.01% | 863 |
|
|
2024
Q4 | $192K | Sell |
12,099
-174,189
| -94% | -$2.76M | ﹤0.01% | 2751 |
|
|
2024
Q3 | $10.8M | Buy |
186,288
+10,593
| +6% | +$615K | 0.01% | 922 |
|
|
2024
Q2 | $8.03M | Buy |
175,695
+156,821
| +831% | +$7.17M | 0.01% | 1004 |
|
|
2024
Q1 | $1.25M | Buy |
+18,874
| New | +$1.25M | ﹤0.01% | 2002 |
|
|
2023
Q2 | – | Sell |
-31,032
| Closed | -$1.33M | – | 3223 |
|
|
2023
Q1 | $1.33M | Buy |
+31,032
| New | +$1.33M | ﹤0.01% | 2045 |
|
|
2022
Q3 | – | Sell |
-21,056
| Closed | -$582K | – | 4040 |
|
|
2022
Q2 | $582K | Buy |
+21,056
| New | +$582K | ﹤0.01% | 2979 |
|
|
2021
Q2 | – | Sell |
-26,142
| Closed | -$1.61M | – | 3648 |
|
|
2021
Q1 | $1.61M | Sell |
26,142
-29,060
| -53% | -$1.79M | ﹤0.01% | 1956 |
|
|
2020
Q4 | $3.89M | Buy |
+55,202
| New | +$3.89M | ﹤0.01% | 1430 |
|